Science Explorer Interactive view Map
Company · Durham · United States

Aerie Pharmaceuticals (United States)

Research works
60
▲ 58% vs 2013–17
Citations
1.3k
21.6 per fractional work
Top-10% rate
42.4%
record average 16.5%
Open access
63%
world 28%

Not ranked overall: Aerie Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.87× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 2.05× its world share, 0 worksNeuroscienceEngineering: 0.04× its world share, 0 worksEngineeringMedicine: 4.42× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.26× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.

Who are the top researchers at Aerie Pharmaceuticals (United States)?

Ranked on the composite score, Casey Kopczynski lead among researchers whose main affiliation is Aerie Pharmaceuticals (United States).

  1. 1 Casey Kopczynski United States · #450,669 worldwide 83 citations · 18 works
All ranked researchers at Aerie Pharmaceuticals (United States)

Which keywords describe research at Aerie Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glaucoma, Intraocular Pressure, Retinal Ganglion Cells, Inflammation, Oxidative Stress, Optical Coherence Tomography, Risk Factors and Ocular Hypertension.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glaucoma13▲ 134×3 topics
  2. Intraocular Pressure12▲ 198×2 topics
  3. Retinal Ganglion Cells12▲ 153×2 topics
  4. Inflammation11▲ 7.9×12 topics
  5. Oxidative Stress11▲ 9.8×6 topics
  6. Optical Coherence Tomography10▲ 154×2 topics
  7. Risk Factors10▲ 17×2 topics
  8. Ocular Hypertension10▲ 261×1 topic
  9. Optic Nerve10▲ 174×1 topic
  10. Macular Degeneration8▲ 110×2 topics
  11. Vascular Endothelial Growth Factor7▲ 122×2 topics
  12. Diabetic Retinopathy7▲ 141×1 topic
  13. Retinal Pigment Epithelium7▲ 232×1 topic
  14. Cancer Therapy3▲ 8.7×5 topics
  15. Neuroprotection3▲ 14×3 topics
  16. Anticancer3▲ 26×4 topics
  17. Immune Response3▲ 8.2×4 topics
  18. Anti-inflammatory3▲ 17×3 topics
  19. Flavonoids3▲ 18×2 topics
  20. Oncogenic Mutations3▲ 96×2 topics
  21. Apigenin2▲ 414×1 topic
  22. Baicalein2▲ 414×1 topic
  23. Alzheimer's Disease2▲ 14×3 topics
  24. Mitochondrial Dysfunction2▲ 11×2 topics
  25. OCT Imaging2▲ 118×2 topics
  26. Corneal Biomechanics2▲ 91×1 topic
  27. Keratoconus2▲ 91×1 topic
  28. Cerebrolysin2▲ 128×1 topic
  29. Citicoline2▲ 128×1 topic
  30. Dry Eye Disease2▲ 94×1 topic
  31. Ocular Surface2▲ 94×1 topic
  32. Antioxidant2▲ 4.5×3 topics
  33. BRAF gene2▲ 174×1 topic
  34. MAP Kinase2▲ 174×1 topic
  35. Myopia2▲ 44×2 topics
  36. Macular Hole2▲ 99×1 topic
  37. Vitreoretinal Surgery2▲ 99×1 topic
  38. Anticancer Agents1▲ 9.6×3 topics
  39. Adrenal Insufficiency1▲ 99×1 topic
  40. Corticosteroid Therapy1▲ 83×1 topic

Which research topics does Aerie Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Glaucoma and retinal disorders, Corneal surgery and disorders, Ocular Surface and Contact Lens and Retinal Diseases and Treatments.

  1. 1 Glaucoma and retinal disorders Ophthalmology 1 works
  2. 2 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  4. 4 Retinal Diseases and Treatments Ophthalmology 0 works
  5. 5 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Cerebral Venous Sinus Thrombosis Neurology 0 works
  7. 7 Ion Channels and Receptors Sensory Systems 0 works
  8. 8 Retinopathy of Prematurity Studies Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Intraocular Surgery and Lenses Ophthalmology 0 works
  10. 10 Retinal Development and Disorders Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.2%not open36.8%

World: 28% of research is openly available.

with international co-authors8.1%domestic only91.9%

World: 19% is written across borders.

How has Aerie Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 58% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.